. References 1. Mazzaferri EL Kloos RT . Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer . J Clin Endocrinol Metab 2001 ; 86 : 1447 – 1463 . 2. Hundahl SA Fleming ID Fremgen AM Menck
Search Results
Investigational Therapies for Metastatic Thyroid Carcinoma
R. Michael Tuttle and R. Leboeuf
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach
Clair J. Beard, Shilpa Gupta, Robert J. Motzer, Elizabeth K. O'Donnell, Elizabeth R. Plimack, Kim A. Margolin, Charles J. Ryan, Joel Sheinfeld, and Darren R. Feldman
Cancer Program from 1998 to 2007 were retrospectively reviewed, with 223 patients being on active surveillance. Vascular invasion was present in 27% of patients, status was unknown in 7%, and embryonal predominance was present in 49%; overall
BPI19-018: Cancer Screening Rates and Adherence of Uninsured Cancer Patients in Free Clinics
Katherine Robinson, Amber Todd, Abu-Sayeef Mirza, Madeline Macdonald, Noura Ayoubi, Rahul Mhaskar, Richard Roetzheim, Laurie Woodard, and Smitha Pabbathi
describe the population and statistically significant relationships. Using the ACS cancer screening recommendations, the charts were reviewed for appropriate cancer screening. Results: From manual chart review, 6,958 charts were reviewed and 201 (2
Incorporating New Systemic Therapies in Kidney Cancer Treatment
Eric Jonasch
, Professor, Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, and Vice Chair of the NCCN Guidelines Panel, reviewed the state of the art and new systemic therapies incorporated into the 2017 NCCN Clinical Practice Guidelines
Grade 1 Chondrosarcoma of Bone: A Diagnostic and Treatment Dilemma
R. Lor Randall and William Gowski
: Churchill Livingstone ; 1983 . 2 Lee FY Mankin HJ Fondren G . Chondrosarcoma of bone: an assessment of outcome . J Bone Joint Surg Am 1999 ; 81 : 326 – 328 . 3 Springfield DS Gebhardt MC McGuire MH . Chondrosarcoma: a review
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018
Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Arnold J. Markowitz, Daniel C. Chung, Robert J. Mayer, Scott E. Regenbogen, Amie M. Blanco, Travis Bray, Gregory Cooper, Dayna S. Early, James M. Ford, Francis M. Giardiello, William Grady, Michael J. Hall, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Xavier Llor, Patrick M. Lynch, June Mikkelson, Reid M. Ness, Thomas P. Slavin Jr, Shajanpeter Sugandha, Jennifer M. Weiss, Mary A. Dwyer, and Ndiya Ogba
activity will be issued a certificate of participation. To participate in this journal CE activity: 1) review the educational content; 2) take the posttest with a 66% minimum passing score and complete the evaluation at http
Malignant Biliary Tract Obstruction: Evaluation and Therapy
David Chu and Douglas G. Adler
participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at www.medscapecme.com/journal/jnccn ; (4) view
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016
Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Jason A. Efstathiou, Thomas W. Flaig, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, A. Karim Kader, Adam S. Kibel, Timothy M. Kuzel, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Daniel Petrylak, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Wade J. Sexton, Arlene O. Siefker-Radtke, Guru Sonpavde, Jonathan Tward, Geoffrey Wile, Mary A. Dwyer, and Courtney Smith
01-P All clinicians completing this activity will be issued a certificate of participation. To participate in this journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest
Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer
Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston
in this journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/79469 ; and 4
Management of Primary Central Nervous System Lymphoma
Francois G. El Kamar and Lauren E. Abrey
primary central nervous system lymphomas at presentation . Neurology 2001 ; 57 : 393 – 396 . 13 Jenkins CN Colquhoun IR . Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the
